Hikma Pharmaceutical reported $256M in EBIT for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 2.26B 427M
Bayer BAYN:GR EUR 1.35B 928M
Fresenius FRE:GR EUR 845M 54M
Fresenius Medical Care FMS:US EUR 308.5M 90.65M
Galapagos GLPG:NA EUR -37578000 38.75M
Genmab GEN:DC DKK 1.93B 684M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Hikma Pharmaceutical HIK:LN USD 256M 23M
Lonza Group LONN:SW CHF 699M 1000K
Merck MRK:GR EUR 1.35B 3M
Orion ORNBV:FH EUR 245.4M 163.4M
Recordati REC:IM EUR 129.41M 6.95M
Roche Holding ROG:VX 11.54B 2.84B